;

WELCOME TO THE MPS WEBINAR SERIES

An informative series of webinars about MPS diseases led by experts in the field

This webinar series is initiated, organised, and funded by Takeda

WEBINAR III

THE YIN AND YANG OF DIAGNOSING MPS II: SUSPECTING AND TESTING

PRESENTED BY PROFESSOR ROBERTO GIUGLIANI & PROFESSOR FATIH EZGÜ

 

Please note that this webinar will also be live broadcast in Spanish, Russian, and Turkish.

Mucopolysaccharidosis type II (MPS II) is a rare, genetic, lysosomal storage disease which affects 1 in 162,000 new-borns.¹ It is caused by a progressive and abnormal accumulation of glycosaminoglycan molecules in patients’ cells and soft tissues.²

Learn more about MPS diseases, including:

  • The early red-flag signs and symptoms for suspecting MPS II
  • Traditional and novel MPS testing procedures
  • The optimal procedure for prompting MPS diagnosis
  • The opportunity to ask specialists your questions

Log in, listen, and be inspired to be part of the next generation of MPS specialists.

 

This webinar will also be replayed at 6pm CET on December 10.

 

 

DATE

 

TIME

- CET

* The date and time according to your timezone is:

-

 

ADD TO CALENDAR:

Google Calendar

 

webinar-hcp-1.png

Apple Calendar

 

webinar-hcp-1.png

Outlook Calendar     

 

webinar-hcp-1.png

Professor Roberto Giugliani

 

Roberto Giugliani, MD, PhD, MSc, is Professor at the Department of Genetics of the Federal University of Rio Grande do Sul (UFRGS) and Chief of the Medical Genetics Service of Hospital de Clinicas de Porto Alegre, Brazil. Dr. Giugliani is Researcher level I A of the Brazilian Council for Development of Science and Technology and Director of the WHO Collaborating Center for the Development of Genetic Services in Latin America.

Professor Giugliani's research interest is the field of inborn errors of metabolism, particularly lysosomal disorders.

Professor Roberto Giugliani

Professor Fatih Ezgü

Professor Fatih Ezgü

 

Fatih Ezgü is Professor of Pediatrics and Head of the Department of Pediatric Genetics at Gazi University, Ankara, Turkey. He is also a faculty member at the Department of Pediatric Metabolic Disorders at the same institution. Dr. Ezgü is Vice Head-Coordinator of the Clinical Research Center for Phase 1 Clinical Trials in Metabolic Diseases at the Faculty of Medicine, Gazi University.

Professor Ezgü’s research interests include lysosomal and mitochondrial disorders, clinical dysmorphology, genetic and metabolic bone disease, as well as novel treatments for genetic disorders.

Register your attendance

The contact information collected in this form will be used to subscribe you to receive electronic communication via email. *

You have the right to opt out of receiving electronic communications at any time by using the opt out link in the communication or by contacting us at privacyconnect@takeda.com

For more information on how Takeda processes your personal data, please refer to our Privacy Notice

Ok